Clinical trialNCT02170246CompletedPhase 1Interventional

Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection

SponsorYale UniversityEnrollment21Acute HIV InfectionHIV Infections

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This research project will study whether the drug telmisartan administered in conjunction with antiretroviral therapy (ART) will help reduce nervous system infection with HIV. The investigators are studying the effect of this treatment in people who have contracted HIV infection within the past three weeks, and thus have a form of HIV called acute HIV infection. The investigators will measure biological markers of immune activation in the blood and cerebrospinal fluid to see if telmisartan may reduce the spread of HIV reservoirs in affected patients.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Jintanat Ananworanich, MD, PhD
U.S. Military HIV Research Program, Bethesda, Maryland
Study Chair
clinicaltrials.gov ↗
Nittaya Phanuphak, MD, PhD
Thai Red Cross AIDS Research Centre, Bangkok, Thailand
Principal Investigator
clinicaltrials.gov ↗
Serena Spudich, MD, MA
Yale University
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Thailand

Chulalongkorn University Hospital
Bangkok, Thailand
Thai Red Cross Aids Research Centre
Bangkok, Thailand

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Telmisartan →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 28 Jan 2015
Primary completion: 13 Jun 2018
Completion: 13 Jun 2018
Last update posted: 9 Mar 2020
Registered enrollment: 21
Registry id: NCT02170246

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.